Elizabeth Lorenzi

机构：Berry & Associates (United States) · ORCID：0000-0002-7259-2696

发表论文 54 篇 · 总被引 4251 次 · h-index 21

代表论文

• Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial (2022 · JAMA · 被引 140)
• Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19 (2023 · JAMA · 被引 100)
• Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score–Matched Survival Outcome Comparisons (2023 · Journal of Clinical Oncology · 被引 71)
• Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19 (2023 · JAMA · 被引 67)
• Intravenous Vitamin C for Patients Hospitalized With COVID-19 (2023 · JAMA · 被引 49)
• Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis (2025 · Intensive Care Medicine · 被引 29)